Cell Processing Technologies Market Report 2026

Cell Processing Technologies Market Overview

• Cell Processing Technologies market size has reached to $4.89 billion in 2025 • Expected to grow to $9.24 billion in 2030 at a compound annual growth rate (CAGR) of 13.5% • Growth Driver: Rising Adoption Of Personalized Medicine Fueling The Growth Of The Market Due To Advancements In Genomic Technologies • Market Trend: Automated Solution Enhances Scalability And Efficiency In Cell Therapy • North America was the largest region in 2025.

What Is Covered Under Cell Processing Technologies Market?

Cell processing technologies refer to a set of methods and tools used to isolate, manipulate, expand, and prepare living cells for research, therapeutic, or diagnostic applications. Their primary purpose is to ensure the controlled handling and modification of cells while maintaining their viability, functionality, and safety for downstream use in regenerative medicine, cell therapy, or laboratory studies. The main types of products in cell processing technologies are equipment, consumables, and software. Cell processing equipment refers to specialized instruments and devices designed to manipulate, culture, separate, and prepare living cells for research, therapeutic, or clinical applications. These find applications in oncology, cardiovascular disease, bone repair, neurological disorders, skeletal muscle repair, immune diseases, and others, catering to diverse end users such as pharmaceutical and biotechnology companies, academic research institutes, and others.

What Is The Cell Processing Technologies Market Growth Forecast?

The cell processing technologies market size is expected to see rapid growth in the next few years. It will grow to $9.24 billion in 2030 at a compound annual growth rate (CAGR) of 13.5%. The growth in the forecast period can be attributed to increasing commercialization of cell therapies, growing demand for scalable cell manufacturing, expansion of personalized medicine applications, rising investments in bioprocess automation, increasing regulatory focus on cell processing standards. Major trends in the forecast period include increasing adoption of automated cell processing systems, rising demand for closed-system cell handling technologies, growing integration of digital process monitoring, expansion of single-use consumables, enhanced focus on cell viability and quality control.

Global Cell Processing Technologies Market Segmentation

1) By Product Type: Equipment, Consumables, Software 2) By Application: Oncology, Cardiovascular Disease, Bone Repair, Neurological Disorders, Skeletal Muscle Repair, Immune Diseases, Other Applications 3) By End-User: Pharmaceutical and Biotechnology Companies, Academic Research Institutes, Other End-Users Subsegments: 1) By Equipment: Bioreactors, Centrifuges, Cell Counters, Incubators, Cryopreservation Systems, Cell Washers, Cell Sorters, Microscopes 2) By Consumables: Cell Culture Media, Reagents, Pipettes and Tips, Flasks and Plates, Cryovials, Filters, Disposable Bags, Tubes and Containers 3) By Software: Process Monitoring Software, Data Management Software, Automation Control Software, Quality Control Software, Imaging and Analysis Software, Inventory Management Software

What Is The Driver Of The Cell Processing Technologies Market?

The rising adoption of personalized medicine is expected to propel the growth of the cell processing technologies market going forward. Personalized medicine is a medical approach that involves tailoring treatments to individual patients based on their genetic, environmental, and lifestyle factors to optimize outcomes and improve care. The demand for personalized medicine is increasing due to advancements in genomic technologies, which enable the precise identification of genetic variations and tailored treatments for individuals. Cell processing technologies enhance personalized medicine by enabling precise manipulation and preparation of patient-specific cells, making them essential for tailored therapies. They improve treatment outcomes by ensuring high-quality, viable cells, advancing the development of targeted and effective medical interventions. For instance, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, an increase from 12 approved in 2022. Therefore, the rising adoption of personalized therapies is driving the growth of the cell processing technologies industry.

Key Players In The Global Cell Processing Technologies Market

Major companies operating in the cell processing technologies market are Thermo Fisher Scientific Inc., Danaher Corporation, Cryo-Cell International Inc., Merck KGaA, Becton Dickinson and Company, Lonza Group AG, Terumo Corporation, WuXi AppTec Co. Ltd., Charles River Laboratories International Inc., Bio-Rad Laboratories Inc., PHC Holdings Corporation, Bio-Techne Corporation, StemCell Technologies Inc., Shibuya Corporation, Repligen Corporation, Beckman Coulter Inc., ThermoGenesis Holdings Inc., Ori Biotech Ltd., Biospherix Ltd., Miltenyi Biotec B.V. & Co. KG, Sartorius Stedim Biotech, Cytiva

Global Cell Processing Technologies Market Trends and Insights

Major companies operating in the cell processing technologies market are focusing on developing technologically advanced solutions, such as automated cell therapy manufacturing platforms, to enhance scalability, improve process efficiency, cell quality, and reduce production costs. An automated cell therapy manufacturing platform refers to a fully integrated system that uses advanced robotics, sensors, and software to perform the entire process of producing cell-based therapies with minimal manual intervention. For instance, in March 2025, Limula SA, a Switzerland-based life sciences company, launched LimONE, a fully automated cell therapy manufacturing platform designed to transform the production of advanced therapies such as CAR-T and gene-edited stem cells. It streamlines complex manufacturing processes by integrating a bioreactor and centrifuge into a single, closed device that uses one consumable throughout all development stages. LimONE enables hospitals, biotech firms, and manufacturers to accelerate the transition from research to clinical trials and commercial production, making life-saving, personalized cell and gene therapies more accessible to patients.

What Are Latest Mergers And Acquisitions In The Cell Processing Technologies Market?

In June 2025, StemCell Technologies Canada Inc., a Canada-based biotechnology company, acquired Cellular Highways Ltd. for an undisclosed amount. With this acquisition, StemCell aims to enhance its cell therapy manufacturing capabilities by integrating Cellular Highways’ advanced cell sorting technology, including the VACS-powered Highway1 instrument. Cellular Highways Ltd. is a UK-based biotechnology company specializing in cell processing technologies for research and therapeutic use.

Regional Outlook

North America was the largest region in the cell processing technologies market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Cell Processing Technologies Market?

The cell processing technologies market consists of revenues earned by entities by providing services such as cell isolation, purification, culture, expansion, genetic modification, quality control testing, and cryopreservation. The market value includes the value of related goods sold by the service provider or included within the service offering. The cell processing technologies market also includes sales of cell isolation instruments, automated bioreactors, closed-system processing units, cell counting and analysis devices, and cryopreservation equipment. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Cell Processing Technologies Market Report 2026?

The cell processing technologies market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cell processing technologies industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.